Introduction {#s1}
============

The genus *Salmonella* comprises Gram-negative bacteria and includes two species, *Salmonella bongori* (*S. bongori*) *and Salmonella enterica* (*S. enterica*) [@pone.0003829-Reeves1]. The lineage of *S. enterica* is thought to have branched into several distinct phylogenetic groups or subspecies. *S. enterica* subspecies I is most frequently isolated from avian and mammalian hosts while *S. bongori* and *S. enterica* subspecies II, IIIa, IIIb, IV, VI, and VII are mainly associated with cold-blooded vertebrates [@pone.0003829-Baumler1]. *S. enterica* subspecies are further classified into more than 2000 serovars, which include pathogens having great medical and veterinary importance. These serovars differ greatly in their host range and their degree of host adaptation [@pone.0003829-Baumler1]. For example, *Salmonella enterica* serovar Dublin (*S*. Dublin) infects cattle; *Salmonella enterica* serovar Choleraesuis (*S*. Choleraesuis) infects pigs and other mammals; *Salmonella enterica* serovar Gallinarum (*S*. Gallinarum) infects poultry; *Salmonella enterica* serovar Typhimurium (*S*. Typhimurium) and *Salmonella enterica* serovar Enteritidis (*S*. Enteritidis) infect multiple hosts including humans, rodents, cattle, poultry and sheep; *Salmonella enterica* serovar Typhi (*S*. Typhi) and *Salmonella enterica* serovar Paratyphi (*S*. Paratyphi) infect humans. In humans, the extent of disease caused by different serovars of *S*. *enterica* varies from mild enteritis to the life threatening typhoid fever. No other known bacterial pathogens belonging to a single species show such a remarkable variation in their host specificity. Yet, the close DNA relatedness of the *S*. *enterica* serovars suggests that they are clonal in their origin [@pone.0003829-Baumler1].

Several experimental studies have already been attempted to unravel the mechanistic origins of the host specificity of *S*. *enterica* serovars [@pone.0003829-Uzzau1]--[@pone.0003829-Morgan1]. For instance, it has been shown that the host specificity of *S*. *enterica* serovars in sheep is not related to its ability to invade the intestinal epithelium [@pone.0003829-Uzzau1]. The avirulence of *S*. Gallinarum in mice, however, is due to its inability to enter the intestinal epithelium, whereas in calves it is due to its inability to disseminate from mesenteric lymph nodes [@pone.0003829-Pascopella1], [@pone.0003829-Paulin1]. Another experimental study reports that the host specificity of *S*. *enterica* in chicken and mice primarily occurs at the level of the reticuloendothelial system [@pone.0003829-Barrow1]. Host specificity in *S*. *enterica* serovars thus appears to be a complex phenotype imparted by multiple genes functioning at different stages of infection and cannot be attributed to a single virulence determinant. It is proposed that the genes belonging to *Salmonella* pathogenicity islands, virulence plasmid, fimbrial operons, pseudogenes and lysogenic phages are important in conferring host specificity and restricting the host range [@pone.0003829-Baumler1], [@pone.0003829-Edwards1]. The large number of genes involved perhaps underlies the failure of attempts to extend the host range of host-restricted *Salmonella* by transfer of small segments of a broad host-range serovar genome [@pone.0003829-HansenWester1] and also renders experimental elucidation of the mechanisms underlying host specificity difficult. Nevertheless, *Salmonella* serves as a good model system to understand the phenomenon of host adaptation by bacterial pathogens as the virulence factors of *Salmonella* are well characterized. Elucidation of host adaptation mechanisms is expected to have broad implications for understanding the emergence of new pathogens and for vaccine design.

*Salmonella,* like many pathogenic bacteria, harbors clusters of virulence genes that are acquired by horizontal gene transfer; the evolution of virulence in *Salmonella* is driven by such horizontal gene transfer. These gene clusters, termed *Salmonella* pathogenicity islands (SPIs), are considered to be 'quantum leaps' in bacterial evolution [@pone.0003829-Groisman1]. SPI-1 is located at 63 min in the *S.* Typhimurium genome and is a 40 kb island with a major role in the invasion of host cells [@pone.0003829-Mills1], [@pone.0003829-Collazo1]. SPI-2 is located at 31 min and is also a 40 kb island that confers the ability to survive within host cells, especially macrophages [@pone.0003829-Shea1], [@pone.0003829-Hensel1]. Both SPI-1 and SPI-2 encode different type three secretory systems (TTSS). SPI-3 is located at 82 min, is 17 kb long, and plays a role in intra-macrophage survival and virulence [@pone.0003829-BlancPotard1]. SPI-4 is located at 92 min, is 27 kb long, and is implicated in the adhesion of *Salmonella* to host epithelial cells [@pone.0003829-Gerlach1]. SPI-5 is located at 20 min and is required for enteropathogenicity [@pone.0003829-Wood1]. SPI genes thus encode many virulence factors that are involved directly in manipulating the host system and may be responsible, at least in part, for the host specificity of different *S*. *enterica* serovars.

We hypothesized that the genes that confer host specificity in *S*. *enterica* must have evolved differentially in different serovars in response to the differential influences of their specific hosts. Our aim in this study was to identify SPI genes that are differentially evolved in different *S*. *enterica* serovars. We have chosen *S.* Typhi (Ty2), *S.* Paratyphi A, *S.* Typhimurium, *S.* Enteritidis and *S.* Choleraesuis for our study. Using a molecular evolution and phylogenetics based approach, we identified six genes as 'differentially evolved genes'. Analysis of putative/proven function/s of these differentially evolved genes provides insights into the complex phenomenon of host specificity in *S*. *enterica*.

Results and Discussion {#s2}
======================

Identification of differentially evolved genes {#s2a}
----------------------------------------------

In this study, we have analyzed genes belonging to SPI-1 (39 genes), SPI-2 (38 genes), SPI-3 (6 genes), SPI-4 (5 genes) and SPI-5 (7 genes) of *S.* Typhi (Ty2), *S.* Paratyphi A, *S.* Typhimurium, *S.* Choleraesuis, and *S.* Enteritidis ([Table S1](#pone.0003829.s001){ref-type="supplementary-material"}, [S2](#pone.0003829.s002){ref-type="supplementary-material"}, [S3](#pone.0003829.s003){ref-type="supplementary-material"}, [S4](#pone.0003829.s004){ref-type="supplementary-material"} and [S5](#pone.0003829.s005){ref-type="supplementary-material"}). We have also considered genes located outside SPIs that encode proteins secreted through either SPI-1 or SPI-2 encoded TTSS. Pseudo genes and genes that did not have homologues in all of the serovars considered were excluded from our analysis ([Table S6](#pone.0003829.s006){ref-type="supplementary-material"}). *S*. Gallinarum was very closely related to *S*. Enteritidis with respect to all the above SPI genes (data not shown). Consequently, inclusion of *S*. Gallinarum in our analysis did not alter the results significantly.

Analysis based on non-synonymous distance {#s2b}
-----------------------------------------

To identify differentially evolved genes, we determined the non-synonymous distances (D~N~) between the homologues of individual SPI genes in all possible pairs of the above serovars. D~N~ is a measure of the degree to which two homologous coding sequences differ in their amino acid content. Specifically, it indicates the degree to which two sequences differ at non-synonymous sites, i.e., nucleotide sites at which a substitution causes an amino acid change. Differentially evolved genes are thus expected to have relatively large values of D~N~ in one or more serovar combinations. We therefore examined the maximum value of D~N~ for each gene (out of ten D~N~ values corresponding to ^5^C~2~ = 10 serovar combinations). We found that nine and twenty eight genes had a maximum D~N~ value (D~N~ ^max^) of greater than 0.02 and 0.01 (data not shown) respectively. *sipD*, *sptP*, *prgI*, *sseC*, *sseD*, *sseF*, *ssaI, sifA* and STM1089 are the nine potential 'differentially evolved genes' whose D~N~ ^max^ values were greater than 0.02.

Phylogenetic analysis {#s2c}
---------------------

To establish the differentially evolved genes, we next compared the phylogeny of the nine potential 'differentially evolved genes' identified above (with D~N~ ^max^\>0.02) with the phylogeny of the *S*. *enetrica* species and with the phylogeny of the five pathogenecity islands of *Salmonella* (SPI-1 to SPI-5). We inferred the species phylogeny from *dnaB* and *16S rRNA*, two house keeping genes. The phylogeny of the five pathogenecity islands was inferred from the consensus tree of 95 trees based on 95 SPI genes. Analysis of maximum likelihood (ML) trees of the 95 SPI genes revealed that the phylogeny of *ssaS*, which encodes a protein that is a part of the SPI-2 encoded TTSS apparatus, represents the best tree. (The TREE-PUZZLE 5.2 program was used for all these analysis [@pone.0003829-Schmidt1]).

We employed the Shimodaira-Hasegawa (SH) test [@pone.0003829-Shimodaira1] to verify whether the phylogenies of the nine potential 'differentially evolved genes' were significantly different from those of *dnaB* and *16S rRNA* (representing species phylogeny), and from those of the consensus tree and *ssaS* (representing the phylogeny of pathogenicity islands). A summary of the results of this analysis is presented in [Table 1](#pone-0003829-t001){ref-type="table"}. The phylogenies of six out of the nine genes were significantly (*P*\<0.05) different from those of *dnaB*, *16S rRNA, ssaS* and the consensus tree. *prgI*, *ssaI* and STM1089 failed this test (*P*\>0.05). This analysis demonstarted that the evolution of *sipD*, *sptP*, *sseC*, *sseD*, *sseF* and *sifA* is different from the rest of the genome including the five pathogenecity islands. Hence, we termed these six genes as 'differentially evolved genes' of SPI-1 to SPI-5 ([Table 2](#pone-0003829-t002){ref-type="table"}).

10.1371/journal.pone.0003829.t001

###### Summary of Shimodaira-Hasegawa tests

![](pone.0003829.t001){#pone-0003829-t001-1}

  Data set                                                        *vs. dnaB*    *vs. 16S rRNA*    *vs. ssaS*    *vs. consensus tree*
  ----------- ------------------------------------------------- -------------- ---------------- -------------- ----------------------
  *sipD*                         ***sipD***                      *P\<*0.0001     *P\<*0.0001     *P\<*0.0001        *P\<*0.0001
  *sptP*                         ***sptP***                      *P\<*0.0001     *P\<*0.0001     *P\<*0.0001        *P\<*0.0001
  *prgI*        ***prgI*** [\*](#nt101){ref-type="table-fn"}     *P = *0.0670    *P = *0.0650    *P = *0.0630       *P* = 0.057
  *sseC*                         ***sseC***                      *P\<*0.0001     *P\<*0.0001     *P\<*0.0001        *P\<*0.0001
  *sseD*                         ***sseD***                      *P\<*0.0001     *P\<*0.0001     *P\<*0.0001         *P\<*0.01
  *sseF*                         ***sseF***                      *P\<*0.0001      *P\<*0.05      *P\<*0.0001        *P\<*0.0001
  *ssaI*        ***ssaI*** [\*](#nt101){ref-type="table-fn"}     *P = *0.4320    *P = *0.4280    *P = *0.5620       *P* = 0.3050
  *sifA*                         ***sifA***                      *P\<*0.0001     *P\<*0.0001     *P\<*0.0001        *P\<*0.0001
  *STM1089*    ***STM1089*** [\*](#nt101){ref-type="table-fn"}   *P = *0.0660    *P = *0.1470    *P = *0.0670       *P* = 0.063

These genes failed the SH test

10.1371/journal.pone.0003829.t002

###### Differentially evolved genes of SPI-1 to SPI-5

![](pone.0003829.t002){#pone-0003829-t002-2}

  Gene       SPI    D~N~ ^max^                                                                            Function
  -------- ------- ------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------
  *sipD*    SPI-1     0.0733     Translocon component of SPI-1 encoded TTSS and is required for the secretion of other effector proteins [@pone.0003829-Kaniga1], [@pone.0003829-Collazo2].
  *sptP*    SPI-1     0.0295                               Effector protein of SPI-1 encoded TTSS and is a protein tyrosine phosphatase [@pone.0003829-Kaniga2].
  *sseC*    SPI-2     0.0283     Translocon component of SPI-2 encoded TTSS and is required for the secretion of other effector proteins[@pone.0003829-Nikolaus1], [@pone.0003829-Klein1].
  *sseD*    SPI-2     0.0254     Translocon component of SPI-2 encoded TTSS and is required for the secretion of other effector proteins [@pone.0003829-Nikolaus1], [@pone.0003829-Klein1].
  *sseF*    SPI-2     0.0254                Effector protein secreted through SPI-2 encoded TTSS; involved in positioning of SCV by recruiting dynein [@pone.0003829-Abrahams1].
  *sifA*     \-       0.0321              Effector protein secreted through SPI-2 encoded TTSS; involved in positioning of SCV [@pone.0003829-Beuzon1], [@pone.0003829-Boucrot1].

In ML trees based on *dnaB, 16S rRNA, ssaS* (data not shown) and the consensus tree, serovars did not cluster according to their host specificity. However, in ML trees based on differentially evolved genes, human adapted serovars (*S*. Typhi and *S*. Paratyphi) clustered together ([Fig. 1](#pone-0003829-g001){ref-type="fig"} and [2](#pone-0003829-g002){ref-type="fig"}). Further statistical analysis confirmed that these genes have evolved differentially in different *S*. *enterica* serovars according to their host specificity ([Table 3](#pone-0003829-t003){ref-type="table"}). Next, we examined, whether the evolution of these genes is significantly accelerated in any particular serovar. We compared the branch lengths of each serovar obtained from ML trees based on six differentially evolved genes. Interestingly, we found that the branch lengths of *S*. Typhi and *S*. Paratyphi are significantly larger (4 to 30 fold) than those of other serovars ([Table 4](#pone-0003829-t004){ref-type="table"}). The evolution of the differentially evolved genes thus appears to be accelerated in human specific serovars suggesting a role for these genes in the host adaptation of human specific serovars.

![Molecular phylogeny of *S. enterica* serovars.\
ML trees constructed based on *dnaB*, *16S rRNA*, *sipD* and the consensus tree of SPI-1 to SPI-5 genes. Numbers inside the trees represent support values for the internal branches. Scale bars represent ML distance.](pone.0003829.g001){#pone-0003829-g001}

![Molecular phylogeny of *S. enterica* serovars inferred from differentially evolved genes.\
ML trees constructed based on *sseC*, *sseD*, *sptP*, *sseF* and *sifA*. Numbers inside the trees represent support values for the internal branches. Scale bars represent ML distance.](pone.0003829.g002){#pone-0003829-g002}

10.1371/journal.pone.0003829.t003

###### Comparison of D~N~ values of *S*. *enterica* serovar combinations with similar and dissimilar host specificity[\*](#nt102){ref-type="table-fn"}.

![](pone.0003829.t003){#pone-0003829-t003-3}

                                                  (STM-SEN and STY-SPA) vs. (STY-STM, STY-SEN, SPA-STM and SPA-SEN)[†](#nt103){ref-type="table-fn"}
  ---------------------------------------------- ---------------------------------------------------------------------------------------------------
  ***sipD***                                                                                *P*\<0.00001
  ***sseC***                                                                                 *P*\<0.001
  ***sseD***                                                                                *P*\<0.00001
  ***sptP***                                                                                 *P*\<0.0001
  ***sseF***                                                                                  *P*\<0.05
  ***sifA***                                                                                  *P*\<0.05
  ***prgI*** [\#](#nt104){ref-type="table-fn"}                                               *P* = 0.12
  ***ssaI*** [\#](#nt104){ref-type="table-fn"}                                                 *P* = 1
  ***ssaS*** [\#](#nt104){ref-type="table-fn"}                                                 *P* = 1

Student\'s t-test was performed to calculate the *P* values.

STM- *S.* Typhimurium; SEN- *S.* Enteritidis; STY- *S.* Typhi; SPA- *S.* Paratyphi.

Genes that are not differentially evolved failed this test.

10.1371/journal.pone.0003829.t004

###### Analysis of maximum likelihood branch lengths of different serovars obtained from ML trees based on the differentially evolved genes

![](pone.0003829.t004){#pone-0003829-t004-4}

                                                               *sipD*    *sseC*    *sseD*    *sptP*    *sseF*    *sifA*       (Mean±SE)
  ----------------------------------------------------------- --------- --------- --------- --------- --------- --------- -----------------
  ***S*** **. Typhi** [\*](#nt105){ref-type="table-fn"}        0.10075   0.03843   0.02761   0.04038   0.03097   0.03617    0.0457±0.0112
  ***S*** **. Typhimurium**                                    0.00097   0.00948   0.00001   0.00186   0.00301   0.00001   0.00256±0.00146
  ***S*** **. Paratyphi** [\*](#nt105){ref-type="table-fn"}    0.10075   0.03637   0.02421   0.04355   0.02544   0.03457    0.0441±0.0117
  ***S*** **. Choleraesuis**                                   0.00194   0.01978   0.01895   0.00432   0.02542   0.00099   0.0119±0.00436
  ***S*** **. Enteritidis**                                    0.00097   0.00091   0.00001   0.00183   0.00340   0.00198   0.00152±0.00048

Branch lengths of *S*. Typhi and *S*. Paratyphi are significantly different from those of other serovars (*P*\<0.05; Student\'s t-test), however the difference between themselves is not significant (*P* = 0.92; Student\'s t-test).

Genes encoding the translocon proteins of SPI-1 and SPI-2 encoded TTSSs are differentially evolved {#s2d}
--------------------------------------------------------------------------------------------------

Serovars belonging to *S*. *enterica* possess two TTSS: one encoded in SPI-1 and the other one in SPI-2. The TTSS encoded in SPI-1 is required for the entry of *Salmonella* into the host epithelial cells [@pone.0003829-Galan1], [@pone.0003829-Darwin1]. Entry into the host system is a potential determinant of host specificity [@pone.0003829-Pascopella1]. The TTSS encoded in SPI-2 enables *S. enterica* to modify functions of the host cell, and thus is essential for the survival and replication of *S. enterica* inside host macrophages, which is vital for causing systemic infection [@pone.0003829-Hensel1]. Intracellular survival and replication is also a potential determinant of host specificity [@pone.0003829-Schwan1]. These TTSSs are used by *Salmonella* to inject effector proteins into the host cytoplasm by piercing the cell membrane or the vacuolar membrane. Thus, the translocons of the TTSS encoded in SPI-1 and SPI-2 interact directly with the host epithelial cell membrane and the vacuolar membrane, respectively. Therefore, these membranes are likely to have influenced the evolution of genes encoding the translocon proteins of the TTSSs. Indeed, our analysis revealed that *sipD*, which encodes a translocon protein of SPI-1 encoded TTSS, and *sseC* and *sseD* which encode translocon proteins of SPI-2 encoded TTSS, are differentially evolved.

Differential evolution of *sipD* {#s2e}
--------------------------------

SipD is a translocon protein of SPI-1 encoded TTSS and plays a vital role in the translocation of secreted proteins into host cells [@pone.0003829-Kaniga1], [@pone.0003829-Collazo2]. *sipD* null mutants are non-invasive in cultured epithelial cells [@pone.0003829-Kaniga1]. IpaD of *Shigella* and LcrV of Yersinia are homologues of SipD and are known to localize to the TTSS needle tip; the tip complex assists with the assembly of the translocation pore, serving as an assembly platform [@pone.0003829-Espina1]--[@pone.0003829-Cornelis1]. In our analysis, *sipD* had the maximum D~N~ ^max^ value among the differentially evolved genes, suggesting that *sipD* has evolved maximally differentially among the *S*. *enterica* serovars we considered ([Table 2](#pone-0003829-t002){ref-type="table"}). We therefore examined this gene in detail.

Remarkably, *sipD* showed zero D~N~ and synonymous distance (D~S~) values (data not shown) between *S.* Typhi and *S.* Paratyphi indicating that SipD is identical in human adapted serovars ([Fig. 3A](#pone-0003829-g003){ref-type="fig"}). SipD is also conserved among other serovars that are not well adapted to humans (D~N = ~0.0013 to 0.0026). However, the D~N~ values of *sipD* between human adapted serovars (*S.* Typhi and *S.* Paratyphi) and other serovars (*S.* Typhimurium, *S.* Choleraesuis, and *S.* Enteritidis) were large (0.0719 to 0.0733) ([Fig. 3A](#pone-0003829-g003){ref-type="fig"}). Human adapted serovars thus appear to have evolved a SipD that is different from the SipD of other serovars.

![Differential evolution of *sipD*.\
(A) Non-synonymous distance profile of *sipD*. (B) Expression of SipD of *S.* Typhi but not SipD of *S.* Typhimurium enabled Δ*sipD S.* Typhi to enter HeLa cells. (C) Expression of SipD of either *S.* Typhi or *S.* Typhimurium enabled Δ*sipD S.* Typhimurium to enter HeLa cells. Graphs represent mean % entry and error bars represent standard error. Student\'s t-test was used to calculate the *P* value. (D) RT PCR analysis of expression of *sipD* in different strains of *S*. Typhi and *S*. Typhimurium. *rpoD* expression was used as internal control. STM- *S.* Typhimurium; STY- *S.* Typhi; SCH- *S.* Choleraesuis; SPA- *S.* Paratyphi; SEN- *S.* Enteritidis.](pone.0003829.g003){#pone-0003829-g003}

SipD of human adapted serovars is structurally different from that of other serovars {#s2f}
------------------------------------------------------------------------------------

Alignment of predicted amino acid sequences of SipD revealed many disfavored amino acid changes between positions 180 and 280 and these changes were specific to human adapted serovars ([Fig. S1](#pone.0003829.s009){ref-type="supplementary-material"}; Materials and [Methods S1](#pone.0003829.s008){ref-type="supplementary-material"}). IpaD of *Shigella* shares 40% sequence identity with SipD [@pone.0003829-Kaniga1]. In *Shigella*, central deletions in IpaD corresponding to amino acid positions 180 to 280 of SipD completely eliminate the invasion function of IpaD [@pone.0003829-Picking1]. The region between amino acid positions 180 and 280 thus appears to be important for the function of SipD. Tertiary structure prediction revealed a prominent difference between the structure of the SipD of *S*. Typhimurium and that of *S*. Typhi in regions corresponding to the residues 47 to 57, 197 to 210 and 268 to 282 ([Fig. S2](#pone.0003829.s010){ref-type="supplementary-material"}; [Materials and Methods S1](#pone.0003829.s008){ref-type="supplementary-material"}).

SipD of human adapted serovars is functionally different from that of *S.* Typhimurium {#s2g}
--------------------------------------------------------------------------------------

In order to verify whether the SipD of *S.* Typhi is functionally different from that of *S.* Typhimurium, we performed an invasion assay in HeLa cells. We observed that the wild type *S.* Typhi and *S.* Typhimurium could enter HeLa cells, but Δ*sipD S.* Typhi and Δ*sipD S.* Typhimurium, which lack *sipD*, could not. The entry defect of Δ*sipD S.* Typhi was abolished when the SipD of *S.* Typhi was expressed but not when the SipD of *S.* Typhimurium was expressed. However, the entry defect of Δ*sipD S.* Typhimurium was abolished when the SipD of either *S.* Typhi or *S.* Typhimurium was expressed ([Fig. 3B and C](#pone-0003829-g003){ref-type="fig"}). Similar results were obtained in Intestine 407 cells, a human intestine epithelial cell line ([Fig. S3A and B](#pone.0003829.s011){ref-type="supplementary-material"}). The SipD of *S.* Typhi is thus functionally different from that of *S.* Typhimurium. The expression of *sipD* in all the complimented strains was confirmed by RT PCR ([Fig. 3D](#pone-0003829-g003){ref-type="fig"}). Heterologous SipD expression did not affect the expression of SipC, another TTSS apparatus protein, which suggests that heterologous SipD expression does not interfere with the expression of the TTSS apparatus ([Fig. S3C](#pone.0003829.s011){ref-type="supplementary-material"}; [Materials and Methods S1](#pone.0003829.s008){ref-type="supplementary-material"}).

Typhoid fever, caused by *S.* Typhi, is characterized by a weak inflammatory response and punched out ulcers in the intestine, whereas gastroenteritis, caused by *S.* Typhimurium, is characterized by inflammatory changes involving neutrophil efflux and fluid accumulation without any ulcerations in the intestine [@pone.0003829-Zhang1], [@pone.0003829-Bhan1]. The early interactions of *S.* Typhi and *S.* Typhimurium with intestinal epithelial cells are different [@pone.0003829-Weinstein1]. Moreover, *S.* Typhi, but not *S.* Typhimurium, uses cystic fibrosis transmembrane conductance regulator (CFTR) to enter human epithelial cells [@pone.0003829-Pier1]. Thus, the invasion of human intestinal epithelium by *S.* Typhi is different from that of *S.* Typhimurium. Our analysis suggests that human adapted serovars have evolved a different SPI-1 encoded TTSS needle substructure, made up of a unique SipD that contributes to the ability of the human adapted serovars to colonize the human intestine differently from and perhaps more efficiently than other serovars that cause gastroenteritis. Identification of host proteins that interact with SipD will help understand the precise role of SipD in conferring human specificity to human adapted serovars of *S*. *enterica*.

Though the main contribution of SPI-1 to *Salmonella* pathogenesis is limited to the gastrointestinal phase of the disease, it has been shown recently that SipB, SipC and SipD of SPI-1 have a previously unappreciated role in the long-term systemic infection in mice [@pone.0003829-Lawley1]. It is possible that the SipD of human adapted serovars might play an important role in causing chronic infection and, possibly a carrier state in humans, which is common in typhoid fever caused by human adapted serovars but not in gastroenteritis caused by other serovars like *S.* Typhimurium.

Differential evolution of *sseC* and *sseD* {#s2h}
-------------------------------------------

SseC and SseD along with SseB form the translocon of SPI-2 encoded TTSS. Because of this vital function, SseC and SseD are required for the proliferation of *S. enterica* inside host cells and thus are essential for the virulence of *S. enterica* [@pone.0003829-Nikolaus1], [@pone.0003829-Klein1]. SseD has limited sequence similarity to EspB of enteropathogenic *Escherichia coli*, whereas SseC is a member of the YopB family of translocon proteins involved in pore formation in the target membrane [@pone.0003829-Hensel2].

D~N~ values of *sseC* between *S.* Typhi and *S.* Paratyphi and between *S.* Typhimurium and *S.* Enteritidis (0.0018 and 0.0044 respectively) were significantly smaller than the other combinations of serovars (0.0165 to 0.0283), suggesting that SseC is conserved in human adapted serovars (*S.* Typhi and *S.* Paratyphi) and in serovars that can infect multiple hosts (*S.* Paratyphi and *S.* Typhimurium) ([Fig. 4A](#pone-0003829-g004){ref-type="fig"} and [Table 3](#pone-0003829-t003){ref-type="table"}). Interestingly, in accordance with our observation, it is reported that the *sseC* of human adapted serovars shows a unique genetic polymorphism absent in other serovars [@pone.0003829-Tracz1]. D~N~ values of *sseD* between *S.* Typhi and *S.* Paratyphi and between *S.* Typhimurium and *S.* Enteritidis were zero indicating that SseD is identical in human adapted serovars and in serovars that can infect multiple hosts ([Fig. 4B](#pone-0003829-g004){ref-type="fig"}).

![Differential evolution of *sseC*, *sseD* and *sptP*.\
(A) Non-synonymous distance profile of *sseC*. (B) Non-synonymous distance profile of *sseD*. (C) Non-synonymous distance profile of *sptP*. STM- *S.* Typhimurium; STY- *S.* Typhi; SCH- *S.* Choleraesuis; SPA- *S.* Paratyphi; SEN- *S.* Enteritidis.](pone.0003829.g004){#pone-0003829-g004}

Human adapted serovars thus appear to have evolved different SseC and SseD that result in an altered translocon complex, which probably makes a more stable and effective contact with the phagosomal membrane of human cells enabling these serovars to survive and multiply inside human cells. Similarly, serovars that can infect multiple hosts may also have evolved a different translocon complex that enables contact with the phagosomal membranes of a wide range of hosts. Together, SseC and SseD, might help different serovars to recognize phagosomal membranes of their specific hosts in order to make a membrane pore and translocate effector proteins into host cells. In addition, differential evolution of *sseC* and *sseD* may also explain the differential survival and replication ability of human adapted serovars inside human and murine macrophages [@pone.0003829-Schwan1].

Differential evolution of *sptP* {#s2i}
--------------------------------

*sptP* encodes a 543 amino acid long secretory protein of SPI-1 encoded TTSS and has two functional domains: a tyrosine phosphatase domain (from position 300 to 543) and a GAP (GTPase activating protein) domain (from position 161 to 291) [@pone.0003829-Kaniga2], [@pone.0003829-Stebbins1]. SptP also has a SicP binding domain at its amino terminal (from position 35 to 139). SicP is a chaperone protein that binds to SptP and enables it to pass through the narrow channel of TTSS [@pone.0003829-Fu1]. The cytoskeletal changes that promote the internalization of *Salmonella* are rapidly reversed by the GAP domain of SptP that targets Cdc42 and Rac1 of host cells [@pone.0003829-Fu2]. SptP is also known to inhibit the mitogen-activated protein kinase pathway by inhibiting Raf activation through its tyrosine phosphatase activity [@pone.0003829-Lin1], [@pone.0003829-Murli1].

Like *sipD*, *sptP* is highly conserved in human adapted serovars, *S.* Typhi and *S.* Paratyphi, with a D~N~ value of 0.0048. *sptP* is also conserved among other serovars that are not adapted to humans (D~N~ = 0.0024 to 0.0032). The D~N~ values of *sptP* between human adapted serovars (*S.* Typhi and *S.* Paratyphi) and other serovars (*S.* Typhimurium, *S.* Choleraesuis, and *S.* Enteritidis) were high (0.0266 to 0.0295) suggesting that SptP of human adapted serovars is different from that of other serovars ([Fig. 4C](#pone-0003829-g004){ref-type="fig"}).

*S.* Typhimurium can trigger the migration of neutrophils across a monolayer of polarized colonic epithelial cells, whereas *S.* Typhi cannot elicit this response [@pone.0003829-McCormick1]. Furthermore, *S.* Typhi infection results in markedly reduced IL-8 production compared to infection with *S.* Typhimurium in the intestinal mucosa [@pone.0003829-Raffatellu1]. These reports suggest that unlike *S.* Typhimurium, *S.* Typhi down-regulates the host innate immune response in the intestinal mucosa, which probably helps S. Typhi disseminate into systemic circulation. NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria including *Salmonella* [@pone.0003829-Elewaut1]. We speculate that SptP plays an important role in the differential innate immune response observed between *S.* Typhi and *S.* Typhimurium in the human intestine as SptP is known to inhibit mitogen-activated protein kinase pathway that activates NF-κB [@pone.0003829-Lin1], [@pone.0003829-Murli1].

Differential evolution of *sseF* {#s2j}
--------------------------------

SseF is an effector protein secreted into the host cytoplasm through the SPI-2 encoded TTSS and is required to maintain the *Salmonella*-containing vacuole (SCV) in a juxtanuclear position by recruiting dynein [@pone.0003829-HansenWester2]--[@pone.0003829-Abrahams1]. D~N~ values of *sseF* between *S.* Typhi and *S.* Paratyphi and between *S.* Typhimurium and *S.* Enteritidis were small (0.005 and 0.0069, respectively) compared to other combinations of serovars (0.0121 to 0.0254) ([Fig. 5A](#pone-0003829-g005){ref-type="fig"} and [Table 3](#pone-0003829-t003){ref-type="table"}). SseF is thus conserved in human adapted serovars and serovars that can infect multiple hosts. In support of our observations, *sseF,* like *sseC,* is shown to have a unique genetic polymorphism in human adapted serovars that is absent in other serovars [@pone.0003829-Tracz1]. Different serovars might have evolved different SseF in order to recruit dynein molecules of different hosts. *sseF* may thus be an important determinant of host specificity in human adapted serovars, acting at the intracellular phase of infection.

![Differential evolution of *sseF* and *sifA*.\
(A) Non-synonymous distance profile of *sseF*. (B) Non-synonymous distance profile of *sifA*. STM- *S.* Typhimurium; STY- *S.* Typhi; SCH- *S.* Choleraesuis; SPA- *S.* Paratyphi; SEN- *S.* Enteritidis.](pone.0003829.g005){#pone-0003829-g005}

Differential evolution of *sifA* {#s2k}
--------------------------------

*sifA* encodes an effector protein that is translocated across the SCV membrane into the host cytoplasm through SPI-2 encoded TTSS and is located outside the SPI-2. SifA is necessary for the formation of *Salmonella*-induced filaments and maintains the integrity of SCV by down-regulating the recruitment of kinesin, which is necessary to maintain SCV in a juxtanuclear position [@pone.0003829-Stein1]--[@pone.0003829-Boucrot1].

The D~N~ values of *sifA* between human adapted serovars (*S.* Typhi and *S.* Paratyphi) and other serovars were high (0.0282 to 0.0321), suggesting that SifA of *S.* Typhimurium, *S.* Enteritidis and *S.* Choleraesuis are different from those of human adapted serovars ([Fig. 5B](#pone-0003829-g005){ref-type="fig"}). Alignment of predicted amino acid sequences of SifA from all these serovars revealed many favored and disfavored amino acid substitutions specific to human adapted serovars ([Fig. S4](#pone.0003829.s012){ref-type="supplementary-material"}; [Materials and Methods S1](#pone.0003829.s008){ref-type="supplementary-material"}). Human adapted serovars thus appear to have evolved a different SifA, which might help them maintain the integrity of the SCV in the human intracellular environment. The conserved N terminal motif, WEK(I/M)xxFF, implicated in intracellular targeting, was not altered. The last six amino-acids of SifA (331--336) are important for membrane anchoring and for its biological function [@pone.0003829-Boucrot2]. Interestingly, the cysteine residue at position 331, which may serve as a recognition site for lipidation along with the other two cysteines (positions 333 and 334), was replaced by tyrosine in *S.* Typhi ([Fig. S4](#pone.0003829.s012){ref-type="supplementary-material"}). Lipidation is a post-translational modification and is important for membrane attachment and biological function of many proteins [@pone.0003829-Casey1]. Post-translational modification of SifA in *S.* Typhi may thus be different from other serovars and may be important for the adaptation of *S.* typhi to humans.

Conclusions {#s2l}
-----------

Using a molecular evolution and phylogenetics based approach, we have identified six genes that potentially underlie the host specificity of *S*. *enterica* serovars. Our study demonstrates that the translocon components of both SPI-1 (SipD) and SPI-2 (SseC and SseD) encoded TTSSs have evolved differentially among different serovars of *S*. *enterica*. The translocon components come in direct contact with the host cell membrane/phagosomal membrane which possibly necessitates their differential evolution for specific host adaptation. SseF and SifA, two effector molecules secreted through SPI-2 encoded TTSS, which interact (directly/indirectly) with two motor molecules, dynein and kinesin, whose recruitment influences the intracellular fate of *S*. *enterica*, are also differentially evolved. SptP, which can suppress the innate immune response at the intestinal level facilitating systemic spread of human adapted serovars in humans is also differentially evolved. Differentially evolved genes of SPI-1 encoded TTSS might act at the host cell invasion phase and those related to SPI-2 encoded TTSS might act at the intracellular phase of infection and together contribute to the host specificity of different serovars of *S*. *enterica* that are considered in our study. We recognize that our approach may not yield an exhaustive list of genes that underlie host specificity. Our approach, however, does provide a list of candidate genes that contribute substantially to host specificity. Our novel yet simple approach may be readily extended to other pathogens, such as *Mycobacteria*, whose species differ in their host specificity.

Materials and Methods {#s3}
=====================

Genomic sequences {#s3a}
-----------------

The genome sequences of *S.* Typhimurium LT2 (NC_003197), *S.* Typhi (Ty2) (NC_004631), *S.* Paratyphi A str. ATCC 9150 (NC_006511) and *S.* Choleraesuis str. SC-B67 (NC_006905) were taken from GenBank and the genome sequence of *S.* Enteritidis *PT4* (NCTC 13349) was taken from Sanger Institute webpage (<http://www.sanger.ac.uk/Projects/Salmonella/>). The genomic sequence of *S*. Enteritidis *PT4* (NCTC 13349) is not annotated. In order to obtain the sequences of SPI genes of this serovar we used NCBI BLAST and used *S.* Typhimurium LT2 (NC_003197) SPI gene sequences as query sequence [@pone.0003829-Altschul1].

Non-synonymous distance calculation {#s3b}
-----------------------------------

Non-synonymous distance, D~N~, (the number of non-synonymous substitutions per non-synonymous site) was calculated using the DNA Sequence Polymorphism software DnaSP 4.0 (Version 4.10.9) [@pone.0003829-Rozas1]. Sequences with varied length were trimmed to a uniform length.

Phylogenetic analysis {#s3c}
---------------------

The sequences were aligned using ClustalW2 with default settings [@pone.0003829-Larkin1]. Phylip format of the output file of ClustalW2 was used to infer the phylogeny using TREE-PUZZLE 5.2 program [@pone.0003829-Schmidt1]. Same program was used to construct the consensus tree of 95 genes belonging to SPI-1 to SPI-5. The outtree file was used to construct phylogenic trees using TreeView program [@pone.0003829-Page1]. To test for the significance of differences in likelihoods between trees, we used TREE-PUZZLE 5.2 implementation of the Shimodaira-Hasegawa (SH) test. This test was performed with 1000 resampling using RELL method and 5% significance level was used.

Bacterial strains and growth conditions {#s3d}
---------------------------------------

*Salmonella enterica* serovar Typhi strain CT18 (Obtained from Institute of Microbial Technology, Chandigarh, India) and *Salmonella enterica* serovar Typhimurium 12023 (Gifted by Prof. Michael Hensel, Germany) were used in invasion experiments. Bacteria were routinely cultured in LB medium. The *sipD* deletion strains (Δ*sipD S.* Typhi and Δ*sipD S.* Typhimurium) were grown in medium containing kanamycin (50 µg/ml) and complemented strains carrying plasmids were grown in medium containing ampicillin (50 µg/ml).

Construction of non-polar *sipD* null mutants (Δ*sipD*) of *S.* Typhi and *S.* Typhimurium {#s3e}
------------------------------------------------------------------------------------------

*sipD* gene was deleted using one-step deletion strategy [@pone.0003829-Datsenko1]. *sipD* gene was replaced by kanamycin resistance marker from pKD4 using Lambda Red recombinase system. *sipD* null mutant was confirmed by colony PCR. Same set of primers were used for both *S.* Typhi and *S.* Typhimurium ([Table S7](#pone.0003829.s007){ref-type="supplementary-material"}).

Complementation of Δ*sipD Salmonella* {#s3f}
-------------------------------------

The *sipD* gene from both *S.* Typhimurium and *S.* Typhi was amplified using primers ([Table S7](#pone.0003829.s007){ref-type="supplementary-material"}) having NcoI and SalI restriction enzyme sites. The resulting PCR amplified genes from both the serovars were introduced between the NcoI and SalI sites of the pTrc99aΔLacI plasmid to get pTrc-STM*sipD* and pTrc-STY*sipD*. Then pTrc-STM*sipD* and pTrc-STY*sipD* were electroporated into Δ*sipD S.* Typhi and Δ*sipD S.* Typhimurium to get respective complemented strains.

Invasion assay {#s3g}
--------------

HeLa and Intestine 407 cells were used for the invasion assays. The cells were grown in antibiotic free Dulbecco\'s Modified Eagle\'s Medium (DMEM; Sigma) with 10% fetal calf serum (Sigma) at 37°C and 5% CO~2~. Cells were seeded at a density of 1.5×10^5^ cells per well in a 24-well plate. Bacteria were grown overnight in LB medium at 37°C and then they were subcultured in fresh LB medium at 1:33 ratio. The subcultures were then grown for 3 h after which the bacterial cells were washed in PBS and used to infect HeLa and Intestine 407 cells at a multiplicity of infection of 1:1. After infection, the plates were centrifuged at 1000 rpm for 5 min followed by 20 min incubation at 37°C and 5% CO~2~. The cells were then washed 5--6 times in warm PBS, followed by 30 min incubation in DMEM containing 100 µg/ml gentamicin (Sigma) to get rid of extracellular bacteria. After 30 min, the cells were again washed 3 times with warm PBS and lysed using PBS containing 0.1% TritonX-100 (Sigma), the lysate was plated on LB agar having specific antibiotic and the numbers of bacteria were enumerated after 12 h incubation. The invasion was calculated as the percentage of bacteria that entered as against the pre-inoculum for each strain. The infection was carried out in triplicate wells for each strain and the whole experiment was repeated thrice.

RT-PCR {#s3h}
------

Bacterial RNA was extracted from log phase culture grown in LB using TRI Reagent (Sigma) and treated with RNase-free DNase (Fermantas) to digest the contaminant DNA. The DNA-free RNA was then reverse transcribed using reverse transcription system (Promega) using gene specific primer (*sipD* and *rpoD*) and amplified (35 cycles) by PCR. Primers used are presented in [Table S7](#pone.0003829.s007){ref-type="supplementary-material"}.
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